Supply High Quality 99% Lamotrigine Powder CAS 84057-84-1

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: TGY2022031103
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Product Name: Lamotrigine
• Appearance: White Crystalline Powder
• Certificate: ISO 9001, USP
• Shelf Life: 24 Months
• Storage: Cool Dry Area
• Grade: Pharmaceutical Grade
• Sample: Avaliable
• Service: OEM
• MOQ: 20mg
• Assay: 98%Min, 99% HPLC
• Test Method: USP;GMP
• Transport Package: Boil Bag
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China (Mainland)
• HS Code: 3001200011
• Production Capacity: 1400kg/Month

Product Description

Lamotrigine is a new antiepileptic drug of benzotriazine, which was marketed in China in 2005. The mechanism of action is to inhibit glutamate-induced action potential by blocking voltage-gated sodium channels in the presynaptic membrane and inhibiting pathological glutamate release, thus stabilizing the neuron membrane. Lamotrigine, as a broad-spectrum antiepileptic agent, is mainly used in the monotherapy or adjuvant treatment of partial and systemic epileptic seizures, and can also be used as an emotional stabilizer in the treatment of type I bipolar disorder.

 

product Name	Lamotrigine
Synonyms	3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
Molecular Formula	C9H7Cl2N5
Molecular Weight	256.09
InChI	InChI=1/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
CAS Registry Number	84057-84-1

 

Lamotrigine is an antiepileptic drug belonging in the phenyltriazine class. It is used in the treatment of both epilepsy and as a mood stabilizer in bipolar disorder. Lamotrigine is the first medication since lithium granted Food and Drug Administration (FDA) approval for the maintenance treatment of bipolar type I. It is approved for use in more than 30 countries.

Lamotrigine has relatively few side-effects and does not require laboratory monitoring. While it is indicated for epilepsy and bipolar disorders, there is evidence that lamotrigine could have some clinical efficacy in certain neuropathic pain states.